WO2014098000A1 - Process for preparation of a tricyclic heterocycle - Google Patents

Process for preparation of a tricyclic heterocycle Download PDF

Info

Publication number
WO2014098000A1
WO2014098000A1 PCT/JP2013/083533 JP2013083533W WO2014098000A1 WO 2014098000 A1 WO2014098000 A1 WO 2014098000A1 JP 2013083533 W JP2013083533 W JP 2013083533W WO 2014098000 A1 WO2014098000 A1 WO 2014098000A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
tetrahydroquinoline
tricyclic heterocycle
preparation
stirred
Prior art date
Application number
PCT/JP2013/083533
Other languages
French (fr)
Inventor
Gottumukkala NAGARAJU
Kumar Ray ANMOL
Ramesh Bhai Bhatt HARSHIT
Singh Khanna Mahavir
Nayyar Kaushal
Kumar Thaper Rajesh
Prasad Mohan
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Publication of WO2014098000A1 publication Critical patent/WO2014098000A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Definitions

  • the present invention provides a process for the preparation of a tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds.
  • WO 2003/076442, WO 2006/086484 and CN 101302216 disclose a four-step process for the preparation of tricyclic heterocycle of Formula as depicted below.
  • a bromoethylpyruvate
  • b gCI 2 , 2-methoxyethanol
  • c NaOH, EtOH
  • d Copper chromite
  • the present inventors have developed a short, convenient, - industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I.
  • the process of the present invention does not involve use of costly.reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic purification.
  • a first aspect of the present invention provides a process for the preparation of tricycli heterocycle of Formula I
  • a second aspect of the present invention provides a process for the preparation of tricyclic heterocycle of Formula I
  • a third aspect of the present invention provides a process for the preparation of tricyclic heteroc cle of Formula I
  • a fourth aspect of the present invention provides tricyclic heterocycle of Formula I having less than 0.5% impurity of Formula X as determined by HPLC.
  • a fifth aspect of the present invention provides tricyclic heterocycle of Formula I having less than 0.1% impurity of Formula XI as determined by HPLC.
  • a sixth aspect of the present invention provides tricyclic heterocycle of Formula I having HPLC purity greater than 99%.
  • the present invention provides a short, convenient, industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds.
  • the process of the present invention does not involve use of costly reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic
  • the leaving group "X" may be selected from nucleophiles .
  • exemplary nucleophiles may include halides such as chloride, bromide or iodide or sulphonate esters such as tosylate, besylate, mesylate or triflate.
  • the leaving group may be halide.
  • R may be a straight or branched chain alkyl having 1-6 carbons such as methyl, ethyl, n-propyl or iso-propyl.
  • R may be ethyl.
  • ambient temperature may refer to a temperature of about 15°C to 35°C.
  • 4-tetrahydroquinoline may be prepared by the reaction of 1,2,3, 4-tetrahydroquinoline with acetal in the presence of a base and a phase transfer agent in a solvent at ambient temperature to the reflux temperature of the solvent. Un-reacted 1, 2 , 3 , 4-tetrahydroquinoline, if any, may be removed by adding concentrated hydrochloric acid.
  • reaction of 1, 2 , 3 , 4-tetrahydroquinoline with acetal may be carried out by adding acetal to a reaction mixture containing
  • reaction mixture may be heated to about 60 °C to reflux, stirred and cooled to ambient temperature.
  • De- ionized water may be added and the reaction mixture may be extracted with a chlorinated hydrocarbon such as dichloromethane .
  • Organic layer (s) maybe added into another reaction vessel containing de-ionized water and concentrated hydrochloric acid. Reaction mixture may be stirred at about 10 °C to ambient temperature for about
  • drying accomplished by filtration, concentration, precipitation, cooling, centrifugation or a combination thereof, followed by drying. Any suitable method of drying may be employed such as drying under reduced pressure, vacuum tray drying, air drying or a combination thereof. Traces of un-reacted acetal, if any, may be removed by heating at a temperature of about 50 °C to 80 °C under reduced pressure.
  • 1,2,3 , 4 -tetrahydroquinoline with acetal may be selected from organic and inorganic bases.
  • Exemplary organic bases may include
  • Exemplary inorganic bases may include carbonates, bicarbonates and hydroxides and hydrides of alkali and alkaline earth metals such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate or sodium hydride.
  • alkali metal carbonate such as potassium carbonate may be used.
  • polar aprotic solvents may include amides such as N, N-dimethylformamide or N, N-diethylformamide , sulphoxides such as dimethyl sulphoxide, nitriles such as acetonitrile or benzonitrile , ketones such as acetone, ethyl methyl ketone or methyl iso-butyl ketone, ethers such as tetrahydrofuran or 1,4-dioxane, chlorinated hydrocarbons such as dichloromethane , chloroform or dichloroethane , N-methylpyrrolidone or sulpholane.
  • N, N-dimethylformamide may be used.
  • the phase transfer catalyst to be used for the reaction of 1 , 2 , 3 , 4 -tetrahydroquinoline with acetal may be selected from potassium iodide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrapropylammonium bromide, tributylbenzylammonium chloride, tetraethylammonium bromide, tetrabutylammonium hydrogen sulphate, benzyltrimethylammonium chloride,
  • benzyltriethylammonium chloride tetrabutylammonium acetate, phenyltrimethylammonium chloride or polyethylene glycols.
  • potassium iodide may be used.
  • phase transfer catalyst may be added in an amount ranging from 0.05 to 0.5 mole equivalent per mole equivalent of
  • phase transfer catalyst Preferably, 0.1 mole equivalent of phase transfer catalyst may be added.
  • the process of the present invention provides
  • the inventors of the present invention have performed several experiments for cyclization of
  • cyclization may be carried out in an inert atmosphere by reacting ,1- (2 , 2-dialkoxyethyl) -1,2,3, 4 -tetrahydroquinoline with a Lewis acid in a suitable solvent at a temperature of about 0°C to ambient temperature.
  • Reaction mixture may be stirred for about 15 minutes to 2 hours, quenched with water followed by completely recovering the solvent at about 10°C. to 30°C under reduced pressure .
  • a non-polar organic solvent such as hexane,, cyclohexane or toluene and activated charcoal may be added . Contents may be stirred to obtain crude tricyclic heterocycle of Formula I.
  • Exemplary Lewis acids to be used for cyclization may include aluminium chloride, aluminium bromide, magnesium chloride, titanium tetrachloride, zinc chloride or boron trifluoride etherate .
  • aluminium chloride or aluminium bromide may be used.
  • exemplary solvents to be used for cyclization may include chlorinated hydrocarbons such as dichloromethane, chloroform or dichloroethane , carbon disulphide or aromatic hydrocarbons such as benzene, toluene or xylene.
  • dichloromethane may be used.
  • the present inventors have observed that during quenching of the reaction mixture using water, a complex of tricyclic heterocycle of Formula I with aluminium chloride may be formed.
  • the tricyclic heterocycle of Formula I may be liberated from this complex under acidic conditions such as by adding 0. IN hydrochloric acid or by stirring the organic layer obtained after quenching with water for about 1 to 5 hours .
  • Purification of crude tricyclic heterocycle of Formula I may be carried out by adding an alcohol such as methanol, ethanol, n-propanol or iso-propanol at ambient temperature to about 40 °C followed by addition of 0. IN hydrochloric acid. Reaction mixture may be heated to about 50 °C to reflux. De-ionized water may be added followed by addition of an alkyl acetate solvent such as methyl acetate, ethyl acetate, propyl acetate or butyl acetate. Contents may be stirred for about 10 minutes to 1 hour at about 50°C to reflux. Layers may be separated and the upper layer may be slowly cooled to a temperature of about 5°C to 25°C, stirred and filtered.
  • an alcohol such as methanol, ethanol, n-propanol or iso-propanol
  • Reaction mixture may be heated to about 50 °C to reflux.
  • De-ionized water may be added followed by addition of an alkyl acetate
  • Wet solid may be washed with a pre-cooled mixture of alcohol and de-ionized water followed by drying at about 25 °C to 60 °C under reduced pressure for about 2 to 15 hours.
  • Purification of crude tricyclic heterocycle of Formula I may also be carried out by stirring in a mixture of a solvent such as hexane or cyclohexane and silica gel for about 2 to 5 hours.
  • the process of the present invention provides tricyclic heterocycle of Formula I in greater than 99% yield.
  • Tricyclic heterocycle of Formula I obtained by the process of the present invention contains less than 0.5% of impurity of Formula X, as determined by HPLC. In one embodiment of the present invention, tricyclic heterocycle of Formula I contains less than 0.44% of impurity of Formula X. In another embodiment of the present invention, tricyclic heterocycle of Formula I contains less than 0.13% of impurity of Formula X.
  • Tricyclic heterocycle of Formula I obtained by the process of the present invention, contains less than 0.5% of impurity of Formula XI, as determined by HPLC. In one embodiment of the present invention, tricyclic heterocycle of Formula I contains less than detectable limit of impurity of Formula XI. Tricyclic heterocycle of Formula I, obtained by the process of the present invention, has purity greater than 99%, as determined by HPLC.
  • Reaction mixture was cooled to ambient temperature followed by addition of de- ionized water (4000 mL) and dichloromethane (1000 mL) . Reaction mixture was stirred for about 10 minutes. Layers were separated and dichloromethane (1000 mL) was added to aqueous layer. Contents were stirred for about 10 minutes followed by layer separation. The organic layers were combined.
  • dichloromethane 1000 mL was added to aqueous layer. Contents were stirred for about 10 minutes followed by layer separation. The organic layers were combined.
  • dichloromethane (6500 mL) was added at a temperature of about 25°C to 30 °C. The contents were cooled to about 0°C to 5°C and aluminium chloride (801.15 g) was added. The contents were cooled to about 0°C to 5°C.
  • dichloromethane (500 g in 100 mL dichloromethane) was added slowly in about 15 to 20 minutes. Reaction mixture was stirred for about 30 minutes to 1 hour at about 0°C to 5°C. Progress of the reaction was monitored by high performance liquid chromatography. Reaction mixture was slowly added into another reaction vessel containing pre-cooled de-ionized water (15000 mL) at about 0 °C to 5 °C and stirred for about 10 minutes followed by layer separation. Dichloromethane was recovered completely at about 15°C to 20°C. Hexane (1000 mL) was added followed by recovering the solvent at about 15 °C to 20 °C under reduced pressure . Hexane (15000 mL) and activated carbon (5 g) were added.
  • dichloromethane 800 mL was added at about 25°C to 30°C. The contents were cooled to about 0°C to 5°C and aluminium chloride (128.33 g) was added. The contents were cooled to about 0°C to 5°C followed by slow addition of a solution of
  • dichloromethane (80 g in 320 mL dichloromethane) in about 15 to 20 minutes. Reaction mixture was stirred for about 30 minutes to 1 hour at about 0°C to 5°C. Progress of the reaction was monitored by high performance liquid chromatography. Reaction mixture was slowly added into another reaction vessel containing pre-cooled de-ionized water (560 mL) at about 0°C to 5°C: The contents were stirred for about 10 minutes followed by layer separation. The organic layer was stirred for about 2 hours, washed with de-ionized water (2 x 560 mL) followed by layer separation and solvent recovery at about 35 °C to 50 °C under atmospheric pressure.
  • Hexane (800 mL) and silica gel (100-200 mesh, 40 g) were added to the residue at about 20°C to 25°C.
  • the contents were warmed to about 30°C to 35°C, stirred for about 30 minutes, filtered and washed with hexane (100 mL) .
  • Hexane was recovered under reduced pressure at about 40°C to 45°C, leaving behind reaction mass (about 160 mL) .
  • the reaction mass was cooled to about 0°C to 5°C, stirred for about 3 hours, filtered, washed with chilled hexane (20 mL)and dried under reduced pressure at about 25 °C to about 30 °C for about 7 hours.
  • dichloromethane (2000 mL) in about 100 minutes. Reaction mixture was stirred for about 30 minutes and then slowly added into another reaction vessel containing pre-cooled de-ionized water (4000 mL) at about 0°C to 5°C. The contents were stirred for about 10 minutes followed by layer separation. Dichloromethane layer was stirred for about 3 hours followed by adding potassium carbonate solution (50 g in 160 mL Dl-water) . Dichloromethane was recovered atmospherically at a temperature of about 40°C to 55°C. Traces of dichloromethane were removed by adding hexane (300 mL) . The crude residue was extracted with hexane (5000 mL) at about ,60°C to 65°C. The contents were cooled to ambient temperature, filtered and washed twice with about IN hydrochloric acid (1000 mL) . Water was removed
  • the present invention provides a short, convenient, industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds.
  • the process of the present invention does not involve use of costly reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention provides a process for the preparation of a tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds.

Description

DESCRIPTION
Title of Invention
PROCESS FOR PREPARATION OF A TRICYCLIC HETEROCYCLE
Technical Field
The present invention provides a process for the preparation of a tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds.
Figure imgf000002_0001
Formula I
Background Art
WO 2003/076442, WO 2006/086484 and CN 101302216 disclose a four-step process for the preparation of tricyclic heterocycle of Formula as depicted below.
Figure imgf000002_0002
Formula I Formula V
a: bromoethylpyruvate; b: gCI2, 2-methoxyethanol; c: NaOH, EtOH; d: Copper chromite
The above disclosed process is cumbersome, involves use of costly reagents such as copper chromite or lithium aluminium hydride and requires an additional purification step such as column chromatography for the preparation of tricyclic heterocycle of Formula I. These factors affect the cost and overall yield of the manufacturing process.
Citation List
Patent Literature
PTLl: WO 2003/076442
PTL2: WO 2006/086484
PTL3 : CN 101302216
Summary of Invention
Technical Problem
The present inventors have developed a short, convenient, - industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I. The process of the present invention does not involve use of costly.reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic purification.
Solution to Problem
A first aspect of the present invention provides a process for the preparation of tricycli heterocycle of Formula I
Figure imgf000003_0001
Formula I
comprising reacting 1 , 2 , 3 , 4 -tetrahydroquinoline of Formula
Figure imgf000004_0001
Formula II
with an acetal intermediate of Formula VI
Figure imgf000004_0002
Formula VI
(X= Leaving group; R = alkyl)
to obtain 1- (2 , 2 -dialkoxyethyl) -1, 2 , 3 , 4-tetrahydroquinoline of Formula VII
Figure imgf000004_0003
Formula VII
and cyclizing the
1- (2 , 2 -dialkoxyethyl) -1 , 2 , 3 , 4 -tetrahydroquinoline of Formula VII in the presence of a Lewis acid in a suitable solvent to obtain tricyclic heterocycle of Formula I.
A second aspect of the present invention provides a process for the preparation of tricyclic heterocycle of Formula I
Figure imgf000004_0004
Formula I
omprising reacting 1 , 2 , 3 , 4-tetrahydroquinoline of Formul
Figure imgf000005_0001
Formula II
with acetal intermediate of Formula VIII
Figure imgf000005_0002
Formula VIII
(X= Leaving group)
to obtain 1- (2 , 2 -diethoxyethyl ) -1 , 2 , 3 , 4 -tetrahydroquinoline of Formula IX
Figure imgf000005_0003
Formula IX
and cyclizing the
1- (2 , 2 -diethoxyethyl) -1,2,3, 4 -tetrahydroquinoline of Formula IX in the presence of a Lewis acid in a suitable solvent to obtain tricyclic heterocycle of Formula I.
A third aspect of the present invention provides a process for the preparation of tricyclic heteroc cle of Formula I
Figure imgf000005_0004
Formula I
comprising reacting 1 , 2 , 3 , 4- tetrahydroquinoline of Formula
Figure imgf000006_0001
Formula II
with an acetal intermediate of Formula VIII
Figure imgf000006_0002
Formula VIII
(X= Leaving group)
to obtain 1- (2 , 2-diethoxyethyl) - 1 , 2 , 3 , 4 -tetrahydroquinoline of Formula IX
Figure imgf000006_0003
Formula IX
and cyclizing the
1- (2 , 2-diethoxyethyl) -1,2,3, 4 -tetrahydroquinoline of Formula IX in the presence of aluminium chloride in a suitable solvent to obtain tricyclic heterocycle of Formula I.
A fourth aspect of the present invention provides tricyclic heterocycle of Formula I having less than 0.5% impurity of Formula X as determined by HPLC.
Figure imgf000007_0001
Formula X
A fifth aspect of the present invention provides tricyclic heterocycle of Formula I having less than 0.1% impurity of Formula XI as determined by HPLC.
Figure imgf000007_0002
Formula XI
A sixth aspect of the present invention provides tricyclic heterocycle of Formula I having HPLC purity greater than 99%.
Advantageous Effects of Invention
The present invention provides a short, convenient, industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds. The process of the present invention does not involve use of costly reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic
purification. Description of Embodiments
1 , 2 , 3 , 4-Tetrahydroquinoline of Formula II and acetal (s) of Formulae VI and VIII used in the present invention are available commercially.
The leaving group "X" may be selected from nucleophiles . Exemplary nucleophiles may include halides such as chloride, bromide or iodide or sulphonate esters such as tosylate, besylate, mesylate or triflate. Preferably, the leaving group may be halide.
The substituent "R" in the intermediates of Formula VI may be a straight or branched chain alkyl having 1-6 carbons such as methyl, ethyl, n-propyl or iso-propyl. Preferably, R may be ethyl.
The term "ambient temperature" as used herein may refer to a temperature of about 15°C to 35°C.
1- (2 , 2-Dialkoxyalkyl) - 1 , 2 , 3 , 4-tetrahydroquinoline may be prepared by the reaction of 1,2,3, 4-tetrahydroquinoline with acetal in the presence of a base and a phase transfer agent in a solvent at ambient temperature to the reflux temperature of the solvent. Un-reacted 1, 2 , 3 , 4-tetrahydroquinoline, if any, may be removed by adding concentrated hydrochloric acid.
In a preferred embodiment of the present invention, reaction of 1, 2 , 3 , 4-tetrahydroquinoline with acetal may be carried out by adding acetal to a reaction mixture containing
1, 2 , 3 , 4-tetrahydroquinoline, base and phase transfer catalyst in a solvent at ambient temperature. Reaction mixture may be heated to about 60 °C to reflux, stirred and cooled to ambient temperature.
De- ionized water may be added and the reaction mixture may be extracted with a chlorinated hydrocarbon such as dichloromethane .
Organic layer (s) maybe added into another reaction vessel containing de-ionized water and concentrated hydrochloric acid. Reaction mixture may be stirred at about 10 °C to ambient temperature for about
10 minutes to 3 hours. Isolation of 1- (2 , 2 -dialkoxyethyl) -1, 2 , 3 , 4 -tetrahydroquinoline may be
accomplished by filtration, concentration, precipitation, cooling, centrifugation or a combination thereof, followed by drying. Any suitable method of drying may be employed such as drying under reduced pressure, vacuum tray drying, air drying or a combination thereof. Traces of un-reacted acetal, if any, may be removed by heating at a temperature of about 50 °C to 80 °C under reduced pressure.
The base to be used for the reaction of
1,2,3 , 4 -tetrahydroquinoline with acetal may be selected from organic and inorganic bases. Exemplary organic bases may include
triethylamine, isobutylamine , tributylamine , diisopropylamine , diisopropylethylamine , pyridine, 4 -dimethylaminopyridine (DMAP) , 4-ethylmorpholine, 1 , 8-diazabicyclo [5.4.0] undec-7-ene (DBU) or 1, 4-diazabicyclo [2.2.2] octane . Exemplary inorganic bases may include carbonates, bicarbonates and hydroxides and hydrides of alkali and alkaline earth metals such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate or sodium hydride. Preferably, an alkali metal carbonate such as potassium carbonate may be used.
The solvent to be used for the reaction of
1 , 2 , 3 , 4 -tetrahydroquinoline with acetal may be selected from polar aprotic solvents. Exemplary polar aprotic solvents may include amides such as N, N-dimethylformamide or N, N-diethylformamide , sulphoxides such as dimethyl sulphoxide, nitriles such as acetonitrile or benzonitrile , ketones such as acetone, ethyl methyl ketone or methyl iso-butyl ketone, ethers such as tetrahydrofuran or 1,4-dioxane, chlorinated hydrocarbons such as dichloromethane , chloroform or dichloroethane , N-methylpyrrolidone or sulpholane. Preferably, N, N-dimethylformamide may be used.
The phase transfer catalyst to be used for the reaction of 1 , 2 , 3 , 4 -tetrahydroquinoline with acetal may be selected from potassium iodide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrapropylammonium bromide, tributylbenzylammonium chloride, tetraethylammonium bromide, tetrabutylammonium hydrogen sulphate, benzyltrimethylammonium chloride,
benzyltriethylammonium chloride, tetrabutylammonium acetate, phenyltrimethylammonium chloride or polyethylene glycols.
Preferably, potassium iodide may be used.
The phase transfer catalyst may be added in an amount ranging from 0.05 to 0.5 mole equivalent per mole equivalent of
1, 2 , 3 , 4-tetrahydroquinoline . Preferably, 0.1 mole equivalent of phase transfer catalyst may be added.
The process of the present invention provides
1- (2 , 2 -dialkoxyethyl) -1 , 2 , 3 , 4-tetrahydroquinoline of Formula IX having purity greater than 97%, as determined by gas chromatography.
The inventors of the present invention have performed several experiments for cyclization of
1- (2 , 2 -dialkoxyethyl ) -1, 2 , 3 , 4-tetrahydroquinoline to obtain tricyclic heterocycle of Formula I using various Lewis acids, solvents and temperature range. No cyclization was observed when
1- (2 , 2 -dialkoxyethyl) -1 , 2 , 3 , 4-tetrahydroquinoline was added to magnesium chloride in 2 -methoxyethanol . Changing the solvent from
2-methoxyethanol to toluene resulted in formation of tricyclic heterocycle of Formula I in low yield. When reaction mixture was stirred for longer time, degradation of cyclized product was observed Increase in reaction temperature for improving the yield of the reaction also lead to degradation of the cyclized product. Further experiments revealed that when aluminium chloride was used in place of magnesium chloride, tricyclic heterocycle of Formula I was obtained in good yield. No degradation was observed when aluminum chloride was used for cyclization. Additionally, carrying out cyclization using aluminum chloride at a temperature of about 0°C to about 25°C furnished tricyclic heterocycle of Formula I in good yield. The inventors of the present invention observed that keeping reaction temperature below 0°C affected the purity of tricyclic heterocycle of Formula I whereas increasing reaction temperature above 25°C lead to degradation of tricyclic heterocycle of Formula I .
Accordingly, in a preferred embodiment of the present invention, cyclization may be carried out in an inert atmosphere by reacting ,1- (2 , 2-dialkoxyethyl) -1,2,3, 4 -tetrahydroquinoline with a Lewis acid in a suitable solvent at a temperature of about 0°C to ambient temperature. Reaction mixture may be stirred for about 15 minutes to 2 hours, quenched with water followed by completely recovering the solvent at about 10°C. to 30°C under reduced pressure . A non-polar organic solvent such as hexane,, cyclohexane or toluene and activated charcoal may be added . Contents may be stirred to obtain crude tricyclic heterocycle of Formula I. Exemplary Lewis acids to be used for cyclization may include aluminium chloride, aluminium bromide, magnesium chloride, titanium tetrachloride, zinc chloride or boron trifluoride etherate .
Preferably, aluminium chloride or aluminium bromide may be used. Exemplary solvents to be used for cyclization may include chlorinated hydrocarbons such as dichloromethane, chloroform or dichloroethane , carbon disulphide or aromatic hydrocarbons such as benzene, toluene or xylene. Preferably, dichloromethane may be used. The present inventors have observed that during quenching of the reaction mixture using water, a complex of tricyclic heterocycle of Formula I with aluminium chloride may be formed. The tricyclic heterocycle of Formula I may be liberated from this complex under acidic conditions such as by adding 0. IN hydrochloric acid or by stirring the organic layer obtained after quenching with water for about 1 to 5 hours .
Purification of crude tricyclic heterocycle of Formula I may be carried out by adding an alcohol such as methanol, ethanol, n-propanol or iso-propanol at ambient temperature to about 40 °C followed by addition of 0. IN hydrochloric acid. Reaction mixture may be heated to about 50 °C to reflux. De-ionized water may be added followed by addition of an alkyl acetate solvent such as methyl acetate, ethyl acetate, propyl acetate or butyl acetate. Contents may be stirred for about 10 minutes to 1 hour at about 50°C to reflux. Layers may be separated and the upper layer may be slowly cooled to a temperature of about 5°C to 25°C, stirred and filtered. Wet solid may be washed with a pre-cooled mixture of alcohol and de-ionized water followed by drying at about 25 °C to 60 °C under reduced pressure for about 2 to 15 hours. Purification of crude tricyclic heterocycle of Formula I may also be carried out by stirring in a mixture of a solvent such as hexane or cyclohexane and silica gel for about 2 to 5 hours.
Preparation of tricyclic heterocycle of Formula I may also be carried out without isolation of
1- (2 , 2 -dialkoxyethyl) -1,2,3, 4 -tetrahydroquinoline .
The process of the present invention provides tricyclic heterocycle of Formula I in greater than 99% yield.
Tricyclic heterocycle of Formula I obtained by the process of the present invention contains less than 0.5% of impurity of Formula X, as determined by HPLC. In one embodiment of the present invention, tricyclic heterocycle of Formula I contains less than 0.44% of impurity of Formula X. In another embodiment of the present invention, tricyclic heterocycle of Formula I contains less than 0.13% of impurity of Formula X.
Tricyclic heterocycle of Formula I, obtained by the process of the present invention, contains less than 0.5% of impurity of Formula XI, as determined by HPLC. In one embodiment of the present invention, tricyclic heterocycle of Formula I contains less than detectable limit of impurity of Formula XI. Tricyclic heterocycle of Formula I, obtained by the process of the present invention, has purity greater than 99%, as determined by HPLC.
In the foregoing section, embodiments ar described by way of examples to illustrate the process of invention. However, these are not intended in any way to limit the scope of the present invention. Several variants of the examples would be evident to persons ordinarily skilled in the art which are within the scope of the present invention.
Methods :
Purity by Gas chromatography was determined using Restek Corporation,. Rtx-5 amine capillary column (30 m length x 0.53 mm ID x 3.0 μηι film thickness) with Oven temperature 1' : 50°C, Time l' : 5 min. , Rate λ1' : 20°C/min, Oven temperature λ2': 260°C, Time λ2': 40 min. , Inj ector temperature : 240 °C, Detector temperature : 270 °C, Carrier gas (N2) flow-. 5.0 mL/min. , Makeup (N2) flow: 20.0 mL/min, Split ratio: 10:1, Injection volume: 0.2 uL.
HPLC purity was determined using Agilent Technologies , CAPCELL PAK C18 MG II (250X4.6) mm, 5μτη column with a flow rate 1 mL/min; Column oven temperature 40 °C; Sample oven temperature 25 °C; Detector UV at 265nm; Injection volume 5yL; Run time 40 minutes; Impurity of Formula X: The peak which elutes whose retention time relative to lilolidine is about 2.99 and Impurity of Formula XI: The peak which elutes whose retention time relative to lilolidine is about 2.38. Example 1
Preparation of
1- (2 , 2 -dialkoxyethyl) -1,2,3, -tetrahydroquinoline
Method A: Preparation of
1- (2 , 2-diethoxyethyl) -1, 2 , 3 , 4 -tetrahydroquinoline
1 , 2 ,3 , 4 -tetrahydroquinoline (500 g) was added to a reaction vessel containing N, N-dimethylformamide (1000 mL) at ambient temperature. Anhydrous potassium carbonate (518.8 g) and potassium iodide (62.3 g) were added. Reaction mixture was heated to about 105 °C to 110°C and stirred for about 1 hour. Bromoacetaldehyde diethyl acetal (887.5 g) was slowly added to the above reaction mixture in about 30 minutes. Reaction mixture was heated to about 145 °C. Progress of the reaction was monitored by gas chromatography. Reaction mixture was cooled to ambient temperature followed by addition of de- ionized water (4000 mL) and dichloromethane (1000 mL) . Reaction mixture was stirred for about 10 minutes. Layers were separated and dichloromethane (1000 mL) was added to aqueous layer. Contents were stirred for about 10 minutes followed by layer separation. The organic layers were combined.
In another reaction vessel containing de-ionized water (1000 mL) , concentrated hydrochloric acid (37.5 mL) was added and the contents were cooled to about 10 °C to 15 °C. The combined organic layers, obtained above, were added. Contents were stirred at about 10°C to 15°C for about 2 hours followed by layer separation.
De- ionized water (4000 mL) was added to the organic layer and contents were stirred for about 10 minutes followed by layer separation. Solvent was recovered from the organic layer at a temperature of about 45°C under atmospheric pressure. Traces of un-reacted
bromoacetaldehyde diethyl acetal, if any, were removed by heating at a temperature of about 60 °C to about 65 °C under reduced pressure. Yield: 93%
Purity: 97.33% (by Gas chromatography)
Un-reacted 1 , 2 , 3 , 4 -tetrahydroquinoline : <0.1%
Un-reacted bromoacetaldehyde diethyl acetal: <0.15%
Method B: Preparation of
1- (2 , 2-dimethoxyethyl) -1,2,3, 4 -tetrahydroquinoline
1 , 2 , 3 , 4 -tetrahydroquinoline (500 g) was added to a reaction vessel containing N, N-dimethylformamide (1000 mL) at ambient temperature. Anhydrous potassium carbonate (778.25 g) , potassium iodide (62.3 g) and bromoacetaldehyde dimethyl acetal (729.62 g) were added. Reaction mixture was heated to about 120°C to 125°C. Progress of the reaction was monitored by gas chromatography. Reaction mixture was cooled to ambient temperature followed by addition of de-ionized water (4000 mL) and dichloromethane (2000 mL) . Reaction mixture was stirred for about 10 minutes. Layers were separated and
dichloromethane (1000 mL) was added to aqueous layer. Contents were stirred for about 10 minutes followed by layer separation. The organic layers were combined.
In another reaction vessel containing de-ionized water (4000 mL) and concentrated hydrochloric acid (37.5 mL) , the combined organic layers, above obtained, were added. Contents were stirred at about 25 °C to 30 °C for about 10 to 15 minutes followed by layer separation. The organic layer was added to a mixture of de-ionized water (4000 mL) and concentrated hydrochloric acid (37.5 mL) . Contents were stirred at about 25°C to 30°C for about 10 to 15 minutes followed by layer separation . The organic layer was added to a mixture of de-ionized water (4000 mL) and concentrated hydrochloric acid (37.5 mL) . Contents were stirred at about 25°C to 30°C for about 10 to 15 minutes followed by layer separation. De-ionized water (4000 mL) was added to the organic layer and the contents were stirred for about 10 minutes followed by layer separation. Solvent was recovered from the organic layer at a temperature of about 35°C to 55°C under atmospheric pressure. Traces of the solvent were removed by drying at a temperature of about 60°C to 65°C under reduced pressure for 1 hour.
Yield: 92.53%
Purity: 97.61% (by Gas chromatography)
Un-reacted 1 , 2 , 3 , 4-tetrahydroquinoline : 0.09%
Un-reacted bromo acetaldehyde dimethyl acetal : 0.23%
Example 2
Cyclization of
1- (2 , 2-dialkoxyethyl) -1 , 2 , 3 , 4-tetrahydroquinoline
Method A: Cyclization of
1- (2 , 2 -diethoxyethyl) -1,2,3, 4-tetrahydroquinoline
In a reaction vessel flushed with nitrogen gas,
dichloromethane (6500 mL) was added at a temperature of about 25°C to 30 °C. The contents were cooled to about 0°C to 5°C and aluminium chloride (801.15 g) was added. The contents were cooled to about 0°C to 5°C. A 'solution of
1- (2 , 2-diethoxyethyl) -1,2,3, 4-tetrahydroquinoline in
dichloromethane (500 g in 100 mL dichloromethane) was added slowly in about 15 to 20 minutes. Reaction mixture was stirred for about 30 minutes to 1 hour at about 0°C to 5°C. Progress of the reaction was monitored by high performance liquid chromatography. Reaction mixture was slowly added into another reaction vessel containing pre-cooled de-ionized water (15000 mL) at about 0 °C to 5 °C and stirred for about 10 minutes followed by layer separation. Dichloromethane was recovered completely at about 15°C to 20°C. Hexane (1000 mL) was added followed by recovering the solvent at about 15 °C to 20 °C under reduced pressure . Hexane (15000 mL) and activated carbon (5 g) were added. The contents were heated to about 30 °C, stirred for about 30 minutes and filtered. Wet cake was washed with hexane (1000 mL) followed by completely recovering hexane at about 35 °C to 40 °C under reduced pressure.
Methanol (2250 L) was added to the crude product at about 35 °C to 60 °C followed by heating to about 65 °C. Extent of purification was monitored using thin layer chromatography. De-ionized water (2000 mL) was slowly added to the reaction vessel at about 60 °C to 65°C followed by addition of ethyl acetate (500 mL) . Reaction mixture was stirred for about 30 minutes at about 60 °C to 65 °C followed by layer separation. Lower light yellow layer was separated completely and the upper layer was slowly cooled to about 10 °C to 15 °C, stirred for about 2 hours and filtered. Wet solid was washed with pre-cooled mixture of methanol (250 mL) and de-ionized water (250 mL) and dried under reduced pressure at about 30°C to 35°C for about 8 hours to 10 hours till moisture content less than 0.2% was achieved.
Yield: 34.9%
Purity: 99.42% (by HPLC)
Impurity of Formula X: 0.124%
Impurity of Formula XI : Not detected
Method B: Cyclization of
1- (2 , 2-diethoxyethyl) -1, 2, 3 , 4-tetrahydroquinoline
In a reaction vessel flushed with nitrogen gas,
dichloromethane (800 mL) was added at about 25°C to 30°C. The contents were cooled to about 0°C to 5°C and aluminium chloride (128.33 g) was added. The contents were cooled to about 0°C to 5°C followed by slow addition of a solution of
1- (2 , 2-diethoxyethyl) -1,2,3, 4 -tetrahydroquinoline in
dichloromethane (80 g in 320 mL dichloromethane) in about 15 to 20 minutes. Reaction mixture was stirred for about 30 minutes to 1 hour at about 0°C to 5°C. Progress of the reaction was monitored by high performance liquid chromatography. Reaction mixture was slowly added into another reaction vessel containing pre-cooled de-ionized water (560 mL) at about 0°C to 5°C: The contents were stirred for about 10 minutes followed by layer separation. The organic layer was stirred for about 2 hours, washed with de-ionized water (2 x 560 mL) followed by layer separation and solvent recovery at about 35 °C to 50 °C under atmospheric pressure. Hexane (800 mL) and silica gel (100-200 mesh, 40 g) were added to the residue at about 20°C to 25°C. The contents were warmed to about 30°C to 35°C, stirred for about 30 minutes, filtered and washed with hexane (100 mL) . Hexane was recovered under reduced pressure at about 40°C to 45°C, leaving behind reaction mass (about 160 mL) . The reaction mass was cooled to about 0°C to 5°C, stirred for about 3 hours, filtered, washed with chilled hexane (20 mL)and dried under reduced pressure at about 25 °C to about 30 °C for about 7 hours.
Yield: 35.7%
Purity: 99.52% (by HPLC)
Impurity of Formula X: 0.43%
Impurity of Formula XI : Not detected
Method C: Cyclization of
1- (2,2-dimethoxyethyl ) -1,2,3,4 -1etrahydroquinoline
In a reaction vessel flushed with nitrogen gas,
dichloromethane (5000 mL) was added at about 25°C to 30°C followed by addition of aluminum chloride (980 g) and a solution of l-(2,
2 -dimethoxyethyl) -1 , 2 , 3 , 4 -tetrahydroquinoline (500 g) in
dichloromethane (2000 mL) in about 100 minutes. Reaction mixture was stirred for about 30 minutes and then slowly added into another reaction vessel containing pre-cooled de-ionized water (4000 mL) at about 0°C to 5°C. The contents were stirred for about 10 minutes followed by layer separation. Dichloromethane layer was stirred for about 3 hours followed by adding potassium carbonate solution (50 g in 160 mL Dl-water) . Dichloromethane was recovered atmospherically at a temperature of about 40°C to 55°C. Traces of dichloromethane were removed by adding hexane (300 mL) . The crude residue was extracted with hexane (5000 mL) at about ,60°C to 65°C. The contents were cooled to ambient temperature, filtered and washed twice with about IN hydrochloric acid (1000 mL) . Water was removed
azeotropically from the hexane layer. Silica gel (60-120 mesh, 250 g) was added at about 25°C to 30°C. The contents were stirred for about 2 hours, filtered and washed with hexane (300 mL) . Hexane was recovered at about 65 °C to 70 °C under atmospheric pressure. The contents were cooled to about 0°C to 5°C, stirred for about 2 hours, filtered, washed with chilled hexane (160 mL) and dried under reduced pressure at about 25°C to 30°C for about 7 hours.
Yield: 152 g (42.8 ' %)
Purity: 99.57% (by HPLC)
Impurity of Formula X: 0.12%
Impurity of Formula XI : Not detected
Industrial Applicability
The present invention provides a short, convenient, industrially advantageous and cost-effective two-step process for the preparation of tricyclic heterocycle of Formula I which can be used as an intermediate for the preparation of pharmaceutical compounds. The process of the present invention does not involve use of costly reagents such as copper chromite or lithium aluminium hydride and provides tricyclic heterocycle of Formula I of high purity without the need for carrying out chromatographic
purification.

Claims

[Claim 1]
A process for the preparation of tricyclic heterocycle Formula I
Figure imgf000019_0001
Formula I
comprising reacting 1 , 2 , 3 , 4-tetrahydroquinoline of Formula
Figure imgf000019_0002
Formula II
with an acetal intermediate la VI
Figure imgf000019_0003
Formula VI
(X= Leaving group; R = alkyl)
to obtain 1- (2 , 2-dialkoxyethyl) -1 , 2 , 3 , -tetrahydroquinoline of Formula VII
Figure imgf000019_0004
and cyclizing the
1- (2 , 2 -dialkoxyethyl) -1 , 2 , 3 , 4-tetrahydroquinoline of Formula VII in the presence of a Lewis acid in a suitable solvent to obt tricyclic heterocycle of Formula I.
[Claim 2] .
A process for the preparation of tricyclic heterocycle Formula I
Figure imgf000020_0001
Formula I
comprising reacting 1, 2 , 3 , 4 quinoline of Formula
Figure imgf000020_0002
H
Formula II
with acetal intermediate of Formula VII
Figure imgf000020_0003
Formula VIII
(X= Leaving group)
to obtain 1- (2 , 2-diethoxyethyl) -1,2,3, 4-tetrahydroquinoline of Formula IX
Figure imgf000020_0004
Formula IX and cyclizing the
1- (2 , 2-diethoxyethyl) -1,2,3, 4-tetrahydroquinoline of Formula IX in the presence of a Lewis acid in a suitable solvent to obtain tricyclic heterocycle of Formula I . [Claim 3]
A process for the preparation of tricyclic heterocycle of Formula I
Figure imgf000021_0001
Formula I
comprising reacting 1 , 2 , 3 , 4 -tetrahydroquinoline of Formula
Figure imgf000021_0002
Formula II
with an acetal intermediat of Formula VIII
Figure imgf000021_0003
Formula VIII
(X= Leaving group)
to obtain 1- (2 , 2-diethoxyethyl) -1 , 2 , 3 , 4-tetrahydroquinoline of Formula IX
Figure imgf000022_0001
Formula IX
and eyelizing the
1- (2 , 2-diethoxyethyl)-l, 2 ,
3 , 4 -tetrahydroquinoline of Formula IX in the presence of aluminium chloride in a suitable solvent to obtain tricyclic heterocycle of Formula I.
[Claim 4] ' '
A tricyclic heterocycl of Formula I
Figure imgf000022_0002
Formula I
having less than 0.5% impurity of Formula X
Figure imgf000022_0003
Formula X
as determined by HPLC. [Claim 5]
A tricyclic heterocycle of Formula
Figure imgf000023_0001
Formula I having less than 0.1% impurity of Formula
Figure imgf000023_0002
Formula XI as determined by HPLC. [Claim 6]
A tricyclic heterocycl of Formula I
Figure imgf000023_0003
Formula I having HPLC purity greater than
PCT/JP2013/083533 2012-12-17 2013-12-09 Process for preparation of a tricyclic heterocycle WO2014098000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3896/DEL/2012 2012-12-17
IN3896DE2012 2012-12-17

Publications (1)

Publication Number Publication Date
WO2014098000A1 true WO2014098000A1 (en) 2014-06-26

Family

ID=50978332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/083533 WO2014098000A1 (en) 2012-12-17 2013-12-09 Process for preparation of a tricyclic heterocycle

Country Status (1)

Country Link
WO (1) WO2014098000A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02273678A (en) * 1989-03-08 1990-11-08 Kali Chem Pharma Gmbh Novel 1,7-fused 1h-indole-2-carboxylic acid- n-(1,4-benzodiazepine-3-yl)-amide, its production and antagonist to cholecystokinin
JP2005526072A (en) * 2002-03-05 2005-09-02 イーライ・リリー・アンド・カンパニー Kinase inhibitor
JP2008530026A (en) * 2005-02-09 2008-08-07 アーキュール,インコーポレーテッド Maleimide derivatives, pharmaceutical compositions and their use for the treatment of cancer
CN101302216A (en) * 2007-05-11 2008-11-12 上海睿智化学研究有限公司 Preparation of condensed ring indole compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02273678A (en) * 1989-03-08 1990-11-08 Kali Chem Pharma Gmbh Novel 1,7-fused 1h-indole-2-carboxylic acid- n-(1,4-benzodiazepine-3-yl)-amide, its production and antagonist to cholecystokinin
JP2005526072A (en) * 2002-03-05 2005-09-02 イーライ・リリー・アンド・カンパニー Kinase inhibitor
JP2008530026A (en) * 2005-02-09 2008-08-07 アーキュール,インコーポレーテッド Maleimide derivatives, pharmaceutical compositions and their use for the treatment of cancer
CN101302216A (en) * 2007-05-11 2008-11-12 上海睿智化学研究有限公司 Preparation of condensed ring indole compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CASREACT accession no. 40:76995 *
SHIKHALIEV, KH. S. ET AL.: "2,2,4-Trimethylhydroquinolines in the Bischler-Mohlau reaction", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, vol. 39, no. 3, 2003, pages 335 - 339 *
ZHU, G. ET AL.: "Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 12, 2004, pages 3057 - 3061 *

Similar Documents

Publication Publication Date Title
US10450324B2 (en) Methods useful in the synthesis of halichondrin B analogs
KR0162897B1 (en) Process for 1h-imidazo(4,5-c)quinolines
BG63692B2 (en) Derivatives of substituted 2-cyclopentyl-4-/4-fluorophenyl/-7,7-dimethyl-tetrahydroquinoline and methods for their preparation
JP5824448B2 (en) Preparation of morphinan and morphinone compounds
WO2018104953A1 (en) Improved process for the preparation of 7-{4-[4-(2,3-dichlorophenyl)-piperazin-1-yl]butoxy}-2oxo-3,4-dihydro-2h-quinolin-1-yl)methyl dodecanoate
EP3152191A1 (en) Improved process for making duocarmycin prodrugs
CN103694237B (en) A kind of preparation method of anticoagulant apixaban and key intermediate
KR20110130421A (en) Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy)hexyl]amino}-l-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one
WO2008059521A2 (en) Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
WO2014098000A1 (en) Process for preparation of a tricyclic heterocycle
WO2007072506A2 (en) Polymorphic forms of dolasetron mesylate and processes thereof
KR20210104833A (en) Substituted Heterocycle Fusion Gamma-Carboline Synthesis
US8598358B2 (en) Synthetic intermediate of oxazole compound and method for producing the same
Singh et al. The Chemistry of 5-Oxodihydroisoxazoles. II. Photolysis and Pyrolysis of 2-(Isoquinolin-1-yl)-3-methyl-5-oxo-2, 5-dihydroisoxazole-4-carboxylate
EP2264016B1 (en) A process for producing pure form form of 2-Methyl-4-(4-Methyl-1-Piperazinyl)-10h-thieno[2,3-B][1,5] benzodiazepine
TR201901758T4 (en) Preparation of radioiodinated 3-fluoropropyl-nor-beta-cit.
WO2008026220A1 (en) A process for purification of 7-(4-bromobutoxy)-3,4 dihydrocarbostyril, an intermediate for manufacture of aripirazole
KR102213991B1 (en) An Improved manufacturing method of Zabofloxacin
CN114957145B (en) 1,2,4-benzotriazine derivative and preparation method thereof
CN114213410B (en) Synthesis method of aromatic ring [ a ] carbazole compound and aromatic ring [ g ] pyridine indole compound
CN113227045B (en) Synthesis of substituted heterocycle fused gamma-carbolines
EP2451803B1 (en) Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
EP1023290A1 (en) Synthesis of swainsonine salts
CN108276419B (en) The synthetic method of a kind of azoles and quinazoline ternary fused heterocyclic derivative
Csutoras et al. Investigation of the acid-catalyzed rearrangement of morphinans

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13863925

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13863925

Country of ref document: EP

Kind code of ref document: A1